Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Specialty Chemicals

Evonik launches plant-derived squalene

by Michael McCoy
December 29, 2022 | A version of this story appeared in Volume 101, Issue 1

Evonik Industries has launched amaranth oil–derived squalene as an alternative to squalene extracted from shark-liver oil. Squalene is used as an adjuvant to boost vaccine efficiency. Evonik calls its product the first adjuvant-grade squalene to be derived from amaranth, an herbaceous plant cultivated in many parts of the world. Squalene is also extracted from olive oil by the French company Sophim and produced via fermentation by the US firm Amyris.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.